Seeking Alpha

ACOR
  Acorda Therapeutics, Inc. - NASDAQ

10/2/2014, 1:45 PM ET
  • danwslee | Send Message 21 Feb 2012

    Random discovery of the year. ACOR Jul 21, 12 options. Open interests, 2500 calls/2500puts at $25. Someone buy straddle?
    Reply (1)
    • REIT | Send Message 21 Feb 2012
      : i guess worth entering a long position below 23 for a possible 10% gain, add to my watch list thanks for sharing
      ACOR vs. ETF Alternatives
      Company Description
      Acorda Therapeutics, Inc. is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of multiple sclerosis, spinal cord injury & other disorders of the central nervous system.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States